Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Rofo ; 179(3): 282-8, 2007 Mar.
Article in German | MEDLINE | ID: mdl-17301932

ABSTRACT

PURPOSE: Evaluation of bipolar radiofrequency (RF) ablation using internally cooled electrodes in an ex-vivo experiment. MATERIALS AND METHODS: Bipolar RF ablations (n = 154) were performed in ex-vivo bovine liver. Both electrodes with a total length of the active tip of 4 cm were located on the same shaft of an internally cooled applicator. The power output was systematically varied between 20 and 100 watts (W). The energy application was continuous or modulated depending on the tissue resistance. In relationship to the maximum power output, the volume of coagulation was assessed. RESULTS: In continuous energy application the induced volume of coagulation was increased at lower power outputs up to 33.7 cm (3) (20 watts). Parallel to an increased volume of coagulation, the required duration of energy application was increased up to a maximum of 51.6 minutes. Modulation of the power output as a function of the tissue resistance enabled application of a wide range of power outputs (40 - 75 watts) leading to a comparable extent of coagulation with a maximum of 14.9 cm (3) (10 min.), 16.8 cm (3) (15 min.), and 19.1 cm (3) (20 min.). CONCLUSION: Continuous application of RF energy leads to an inverse relationship between volume of coagulation and power output. Modulation of the power output as a function of the tissue resistance enables application of a wider range of power outputs compared to continuous application of RF energy.


Subject(s)
Catheter Ablation/methods , Liver/anatomy & histology , Radiofrequency Therapy , Animals , Calorimetry , Cattle , Organ Size
3.
Pathologe ; 28(1): 51-4, 2007 Feb.
Article in German | MEDLINE | ID: mdl-17146642

ABSTRACT

A 65-year old man presented with acute abdominal pain and fever. The initial diagnosis was small bowel gangrene. Pathology revealed small to large abdominal vessels obliterated by cells of intravascular B-cell-lymphoma (IVL). Visceral IVL involvement is common at autopsy but rarely reported in patients with acute abdomen. The subtype of diffuse large B-cell lymphoma is a rare and aggressive malignancy, which in typical cases is characterized by cephalic or cutaneous manifestation. Few cases showed involvement of large vessels which in combination to fibrin thrombi may lead to infarction of the organ involved. Thus IVL should be considered in cases of ischemic diseases with fever of unknown origin.


Subject(s)
Abdomen, Acute/etiology , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Vascular Neoplasms/pathology , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Fatal Outcome , Fever , Humans , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/surgery , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/surgery , Male , Pain , Phenotype , Prednisone/administration & dosage , Vascular Neoplasms/genetics , Vascular Neoplasms/surgery , Vincristine/administration & dosage
5.
Mund Kiefer Gesichtschir ; 10(2): 118-21, 2006 Mar.
Article in German | MEDLINE | ID: mdl-16496113

ABSTRACT

BACKGROUND: Distant metastases of solid tumors account for about 1% of all malign neoplasms. In about 30% of all patients who present with an oral metastasis, the distant primary tumour has not been diagnosed yet. CASE REPORT: We report the case of a 71-year-old man who clinically demonstrated unilateral mental neuropathy as well as pathologic fracture of the mandible. Prostate carcinoma was identified as a primary tumor. Clinically, there was significant hypesthesia of the skin area innervated by the left inferior alveolar nerve. X-ray examination revealed an osteolytic lesion of the ascending ramus of the mandible as well as a pathologic fracture of the mandible. Further imaging showed an extensive neoplasm of the mandible and adjacent soft tissues and significant supraclavicular lymph node enlargement. The diagnosis of metastatic carcinoma of the prostate was histopathologically confirmed. CONCLUSION: Mental neuropathy without a dental focus indicates screening for an osseous metastasis. In cases of left-sided supraclavicular lymph node enlargement in men over 45 years, metastatic prostate carcinoma must be excluded.


Subject(s)
Fractures, Spontaneous/diagnosis , Mandible/innervation , Mandibular Fractures/diagnosis , Mandibular Neoplasms/secondary , Mandibular Nerve/physiopathology , Paresthesia/diagnosis , Prostatic Neoplasms/diagnosis , Aged , Biopsy , Diagnosis, Differential , Fractures, Spontaneous/pathology , Humans , Magnetic Resonance Imaging , Male , Mandibular Fractures/pathology , Mandibular Neoplasms/diagnosis , Mandibular Neoplasms/pathology , Mandibular Nerve/pathology , Masticatory Muscles/pathology , Paresthesia/pathology , Prostate/pathology , Prostatic Neoplasms/pathology , Radiography, Panoramic , Tomography, X-Ray Computed
6.
Abdom Imaging ; 30(5): 543-7, 2005.
Article in English | MEDLINE | ID: mdl-15891805

ABSTRACT

Preoperative localization of gastrinomas, especially of extrapancreatic origin, remains a challenge to the radiologist. Most patients with extrapancreatic gastrinomas undergo surgery without preoperative identification of the primary tumor. The appropriate imaging modality to localize gastrinomas is under continuing debate. We report a case of a duodenal gastrinoma with regional lymph node metastases that presented with Zollinger-Ellison syndrome. The small primary tumor was detected noninvasively by dual-phase multidetector thin-section computed tomography with adequate bowel distention and confirmed by endoscopy and histopathologic examination. The case illustrates that appropriate computed tomographic technique and scanning protocol are crucial for success in localizing extrapancreatic gastrinoma.


Subject(s)
Duodenal Neoplasms/diagnostic imaging , Gastrinoma/diagnostic imaging , Tomography, X-Ray Computed/methods , Contrast Media , Duodenal Neoplasms/pathology , Duodenal Neoplasms/surgery , Female , Gastrinoma/pathology , Gastrinoma/surgery , Humans , Middle Aged
7.
Leuk Lymphoma ; 44(7): 1251-3, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12916883

ABSTRACT

We report the case of a 76-year old patient with third relapse of AML who was successfully treated with Imatinib. The decision to try Imatinib was guided by bright expression of c-kit on the patient's blasts. Treatment was well tolerated but the dose was reduced for pancytopenia and later stopped completely because of pneumonia. The patient recovered with i.v. antibiotics, antimycotics and s.c. G-CSF. Reevaluation of the bone marrow after the end of treatment demonstrated the absence of malignant blasts. Treatment with Imatinib was started again with the intention to prolong remission duration. During the following months peripheral blood counts stabilized in the normal range indicating that a fourth complete remission has been achieved in this patient. This is the first report demonstrating that Imatinib can induce complete remission in relapsed c-kit positive AML in an elderly patient. Prolonged cytopenia remains a considerable problem indicating that normal haematopoiesis is not completely independent of the signalling cascades inhibited by Imatinib. Nevertheless our report supports further study of this drug in c-kit positive AML.


Subject(s)
Antineoplastic Agents/therapeutic use , Enzyme Inhibitors/therapeutic use , Leukemia, Monocytic, Acute/drug therapy , Neoplasm Recurrence, Local/drug therapy , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Aged , Benzamides , Bone Marrow/pathology , Disease Progression , Drug Resistance, Neoplasm , Humans , Imatinib Mesylate , Leukemia, Monocytic, Acute/pathology , Male , Neoplasm Recurrence, Local/pathology , Protein-Tyrosine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/metabolism , Remission Induction , Salvage Therapy
8.
J Clin Pathol ; 55(7): 554-7, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12101213

ABSTRACT

Primary lymphoma of the urinary bladder is a very rare tumour. A bladder tumour was found in a 57 year old man with obstructive dysuria. It was found by histological and immunohistohistochemical investigation to be an extranodal marginal zone B cell lymphoma. Lymphoepithelial lesions were absent, but were found in a clinically silent gastric lymphoma discovered four weeks later during staging investigations; this gastric lymphoma was negative for Helicobacter pylori by breath test and molecular biological analysis. Sequencing of the clonal immunoglobulin heavy chain gene in both tumours indicated the same precursor cell, of follicular or post follicular origin. In synopsis, the data suggested that this was a case of primary lymphoma of the bladder with involvement of the stomach. The application of a chromosome 3 specific alpha satellite probe revealed trisomy 3. A tumour with these characteristics arising as a lymphoma of the bladder with a metachronous involvement of the gastric mucosa has not been described previously.


Subject(s)
Lymphoma, B-Cell, Marginal Zone/pathology , Stomach Neoplasms/pathology , Urinary Bladder Neoplasms/pathology , Humans , Male , Middle Aged
9.
Mund Kiefer Gesichtschir ; 6(3): 191-6, 2002 May.
Article in German | MEDLINE | ID: mdl-12143132

ABSTRACT

BACKGROUND: Cystic carcinomas of the neck without evidence of a primary tumor are diagnostically challenging lesions. Differentiation between a cystic lymph node metastasis of an occult primary tumor and a carcinoma arising in a branchiogenic cyst is frequently not possible even with histological examination. In order to clarify the diagnosis, an intensive search for a primary lesion in the upper aerodigestive tract must be carried out. DIAGNOSIS: An occult carcinoma might be situated in Waldeyer's ring, especially in the tonsillar crypts. These tumors tend to produce cystic metastases in the jugulodigastric region. Therefore, multiple biopsies have to be taken from the tissue of Waldeyer's ring. In the case of a positive histological result, adequate therapy of both the primary and the metastasis can be carried out. The diagnosis of a malignant branchiogenic cyst is only permissible after a primary lesion has been thoroughly excluded.


Subject(s)
Carcinoma, Squamous Cell/pathology , Cysts/pathology , Lymphatic Metastasis/pathology , Neoplasms, Unknown Primary/pathology , Tonsillar Neoplasms/pathology , Aged , Diagnosis, Differential , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Palatine Tonsil/pathology
10.
Br J Dermatol ; 144(6): 1239-43, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11422050

ABSTRACT

Rituximab, a chimeric anti-CD20 monoclonal antibody, has been approved for systemic treatment of relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma. As cutaneous B-cell lymphoma (CBCL) also expresses the CD20 molecule, three patients with histologically and immunohistochemically confirmed CBCL without systemic involvement were treated with low-dose intralesional rituximab in a pilot study. Single doses applied ranged from 10 to 30 mg per lesion, according to lesion extent, with a cumulative dose of up to 350 mg. Injections were given two or three times weekly for 3-5 weeks, with a second cycle after 6 weeks in one patient with incomplete remission. Complete and lasting remission was achieved in each patient; this has persisted for up to more than 1 year. The observed adverse events were of grade 1 severity. Results suggest that intralesional rituximab may be a safe and effective new therapy modality for CBCL.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Lymphoma, B-Cell/therapy , Skin Neoplasms/therapy , Adult , Aged , Antibodies, Monoclonal, Murine-Derived , Female , Humans , Injections, Intralesional , Lymphoma, B-Cell/pathology , Male , Pilot Projects , Rituximab , Skin Neoplasms/pathology
11.
Mol Pathol ; 53(2): 83-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10889907

ABSTRACT

BACKGROUND: Although numerous antibodies suitable for use on paraffin wax embedded sections are available for the subtyping of acute leukaemia (acute myelogenous leukaemia (AML) and acute lymphoblastic leukaemia (ALL)) in bone marrow biopsy sections, unequivocal identification of the cell line involved is sometimes impossible. METHODS: Forty eight formalin fixed, paraffin wax embedded bone marrow biopsy specimens that had been decalcified in EDTA were investigated, including 42 thought to exhibit ALL on the basis of bone marrow smears. Five specimens exhibited AML and one biphenotypic leukaemia, as diagnosed immunohistochemically in bone marrow biopsies. Immunostaining was performed with antibodies against relatively specific B and T cell antigens. The blasts were investigated for rearrangements of the immunoglobulin heavy chain (IgH) and the T cell antigen receptor (TCR) genes. RESULTS: Amplifiable DNA was obtained from all 48 specimens. An IgH gene rearrangement was detected in 20 of 23 c-ALL specimens. Four of seven T cell ALL (T-ALL) specimens had a TCR-gamma gene rearrangement, and the one B cell ALL (B-ALL) specimen exhibited a clonal IgH gene. Three of four cases of unclassifiable ALL could be assigned to the B cell lineage on the basis of gene rearrangement analysis. Seven cases originally diagnosed in smears as ALL were rediagnosed as AML (n = 5) or biphenotypic leukaemia (n = 2) because of immunohistochemical reactivity for myeloperoxidase or lysozyme. Two of these AML cases and two of three cases of biphenotypic leukaemia exhibited a monoclonal IgH gene rearrangement. CONCLUSIONS: Acute leukaemia can be subtyped in bone marrow sections with a limited panel of antibodies suitable for use on paraffin wax embedded sections (against CD3, CD10, CD20, CD79a, myeloperoxidase, and lysozyme). In patients with ALL and a diagnostically equivocal immunophenotype, gene rearrangement analysis might indicate whether the B or T cell lineage is involved.


Subject(s)
Gene Rearrangement , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , B-Lymphocytes/immunology , Bone Marrow Cells/immunology , Bone Marrow Examination , Cell Lineage , DNA/analysis , Humans , Immunoglobulin Heavy Chains/genetics , Immunohistochemistry , Leukemia, Myeloid, Acute/diagnosis , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/immunology , Paraffin Embedding , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Predictive Value of Tests , T-Lymphocytes/immunology
12.
Mund Kiefer Gesichtschir ; 4(1): 53-6, 2000 Jan.
Article in German | MEDLINE | ID: mdl-10662923

ABSTRACT

Paragangliomas of the glomus caroticum are relatively rare, but highly vascularized neoplasmas, which develop from chemoreceptors. They can be develop at any age, but most often in the third or fourth decade of life. Paragangliomas grow very slowly and are most always of benign origin. There is a familial predisposition, and an autosomal-dominant transmission is presumed. They are commonly located in the jugular region; in rare cases a polytopic manifestation is found. We describe the case of a 47-year-old male patient who was referred to our department because of a progressive swelling of the neck on both sides. Contrast-enhanced computed tomography had displayed soft tissue tumors in the jugular regions. We performed an operative exploration, which showed a highly vascularized tumor. Histopathologic analysis revealed the diagnosis of a paraganglioma. An angiography of the neck and thoracic region, furthermore, revealed an additional paraganglioma in the anterior mediastinum. Using a surgical approach via lateral cervicotomies and thoracotomy the paragangliomas were extirpated. Our case report demonstrates the rare polytopic manifestation of paragangliomas. This perivascular neoplasms have to be removed before haemodynamic complications develop. The extent of this tumors is clearly illustrated by use of an angiography. Because of the familial predisposition, clinical and radiological examinations of relatives are mandatory.


Subject(s)
Carotid Body Tumor/diagnosis , Neoplasms, Multiple Primary/diagnosis , Carotid Body/pathology , Carotid Body Tumor/pathology , Carotid Body Tumor/surgery , Diagnostic Imaging , Humans , Male , Middle Aged , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Reoperation
13.
J Clin Pathol ; 52(7): 521-6, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10605406

ABSTRACT

BACKGROUND: Slight, diffuse or focal lymphocyte proliferation is relatively common in bone marrow biopsy specimens. It may be impossible to determine whether this represents a reactive lymphocytosis or low grade non-Hodgkin lymphoma (NHL) on the basis of routine investigations alone. AIM: To investigate the supplementary use of molecular biological techniques in this situation. METHODS: 529 formalin fixed, paraffin embedded bone marrow biopsy specimens from the iliac crest were subjected to histological and immunohistochemical staining to determine the number and nature of the lymphocytes present. The cases were divided into three groups according to the lymphocyte count: normal (< 10% of nucleated bone marrow cells), slightly increased (10-30%), and markedly increased (> 30%). All of the last group could be diagnosed as NHL from the morphological findings alone. The clonality of rearrangements of the IgH and TCR gamma genes was investigated by polymerase chain reaction (PCR). RESULTS: Monoclonality was observed in 7.5% of the 372 cases with a normal lymphocyte count, in 50% of the cases with a modest increase in lymphocyte numbers (suggesting a diagnosis of low grade NHL not detected by immunostaining), and in 77% of the cases with markedly increased lymphocyte numbers. CONCLUSIONS: If PCR is used in addition to the immunohistochemical investigation of bone marrow biopsies, considerably more cases of NHL can be identified, making this of particular use in staging and detection of recurrences.


Subject(s)
Bone Marrow Cells/immunology , Lymphoma, Non-Hodgkin/diagnosis , Diagnosis, Differential , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Humans , Immunohistochemistry , Lymphocyte Count , Lymphocytosis/diagnosis , Lymphocytosis/genetics , Lymphocytosis/immunology , Lymphoma, Non-Hodgkin/genetics , Lymphoma, Non-Hodgkin/immunology , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/immunology , Polymerase Chain Reaction , Sensitivity and Specificity
14.
Am J Dermatopathol ; 21(2): 156-60, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10218676

ABSTRACT

We describe a case of granulomatous mycosis fungoides, tumor stage, mimicking sarcoidosis in an 82-year-old man with a 2-year history of skin disease. The final diagnosis was established after one of seven biopsy specimens showed a nongranulomatous histologic picture of patch-stage mycosis fungoides. Monoclonality was proven for the lymphocytic population by T-cell-receptor rearrangement studies. The unusually extensive granulomatous inflammation with huge giant cells surrounded by CD1a-positive cells in the other six biopsy specimens was suggestive of the histopathology of granulomatous slack skin, another rare granulomatous cutaneous T-cell lymphoma. Because both a clinical and histologic overlap between granulomatous mycosis fungoides and granulomatous slack skin have been reported in the literature, we conclude that they may belong to the spectrum of a single disease.


Subject(s)
Granuloma/pathology , Mycosis Fungoides/pathology , Skin Neoplasms/pathology , Aged , Aged, 80 and over , Diagnosis, Differential , Humans , Lymphoma, T-Cell, Cutaneous/pathology , Male , Sarcoidosis/pathology , Skin/pathology
15.
Verh Dtsch Ges Pathol ; 82: 279-83, 1998.
Article in German | MEDLINE | ID: mdl-10095447

ABSTRACT

Giant cell tumour (GCT) of bone is a locally aggressive tumour with a high rate of recurrence if not completely excised. The present study was undertaken to clarify whether flow cytometric, immunohistochemical and morphometric studies can be a useful tool to assess the prognosis of patients with GCT. DNA flow cytometry, cell cycle studies and immunohistochemical investigations with antibodies against CD 68, CD 34, p53 and Ki67 were performed on paraffin embedded tissue of 10 cases of GCT. As a further possible prognostic parameter angiogenesis within the tumour was investigated using an automatic image analysis system. Histologically 4 cases were grade 1 tumours and 6 cases grade 2. Among the Grade 1 cases, all were diploid. Of the Grade 2 cases, 4 were diploid and 2 were aneuploid. Both of the patients with an aneuploid tumour developed a loval recurrence. All GCT revealed large numbers of CD 68 positive giant cells, but mononuclear tumour cells exhibiting CD 68 immunoreactivity were also present. Corresponding to the immunohistochemical findings with MIB-1 the flow cytometric DNA histogram revealed high proliferation rates (mean value 14.9%). None of the tumours exhibited p53 immunoreactive cells. All cases showed high content of vessels with on the average relative vessel area of 7.7%. No correlation between clinical outcome and vascular parameters (number of vessels, vessel area, perimeter) was found. Our findings suggest that DNA flow cytometry is useful in predicting tumour behaviour in some cases. GCT exhibits extensive angiogenesis, but none of the vascular parameters investigated was found to be of prognostic value.


Subject(s)
Bone Neoplasms/genetics , Bone Neoplasms/pathology , DNA, Neoplasm/genetics , Giant Cell Tumors/genetics , Giant Cell Tumors/pathology , Antigens, CD/analysis , Cell Cycle , DNA, Neoplasm/analysis , Diploidy , Flow Cytometry/methods , Humans , Immunohistochemistry/methods , Ki-67 Antigen/analysis , Mitotic Index
16.
J Clin Pathol ; 50(6): 525-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9378823

ABSTRACT

Mast cells are now known to derive from CD34+ haemopoietic stem cells in the bone marrow. However, it has not yet been established whether the various types of mastocytosis, which involve tumour-like proliferation of mast cells, are true neoplastic disorders or reactive/hyperplastic conditions. In this study, tissue specimens (five bone marrow, two spleen, one skin) from female patients with histologically confirmed mastocytosis were investigated with a recently developed polymerase chain reaction assay for the determination of clonality of female cells using the human androgen receptor gene (HU-MARA). Mast cells purified to near homogeneity from hysterectomy specimens served as a control. The findings in bone marrow and skin either were not reproducible, or indicated polyclonality. However, both spleen specimens exhibited monoclonality. In addition, DNA analysis by flow cytometry was performed and revealed a diploid chromosome content with proliferation indices of under 8% in all the specimens. This is the first molecular biological study to indicate that mastocytosis is indeed neoplastic in nature.


Subject(s)
Mastocytosis/pathology , Case-Control Studies , Female , Flow Cytometry , Humans , Mastocytosis/genetics , Polymerase Chain Reaction , Receptors, Androgen
SELECTION OF CITATIONS
SEARCH DETAIL
...